Prevention of glucocorticoid-induced osteoporosis.

Academic Article

Abstract

  • Patients taking low-dose glucocorticoids for 3 months or more are at risk for rapid bone loss. The loss may be as high as 15% in the first 3 to 6 months of treatment, and can lead to osteoporotic fractures, with an increase in morbidity and mortality. This article discusses an evidence-based approach to the prevention of glucocorticoid-induced osteoporosis.
  • Authors

    Published In

    Keywords

  • Alendronate, Algorithms, Calcitonin, Diphosphonates, Etidronic Acid, Glucocorticoids, Humans, Osteoporosis, Parathyroid Hormone, Risedronic Acid
  • Author List

  • Saag KG
  • Start Page

  • 555
  • End Page

  • 558
  • Volume

  • 97
  • Issue

  • 6